Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Atherosclerotic Plaques in Clinical Use

NCT01707615 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 287

Last updated 2012-10-16

No results posted yet for this study

Summary

The purpose of this study is to investigate the antiatherogenic effect of GSPE in clinical use

Conditions

  • Atherosclerosis of Arteries of the Extremities, Unspecified

Interventions

DRUG

GSPE

GSPE 240 mg/day (120mg bid)

OTHER

lifestyle intervention

dietary modification making the total ingestion of calories into standard body weight 25 kCal in effect and an individualized home exercise program of a minimum 150 min/week of moderate-intensity physical activity

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV
  • Jie Qiu

    lead OTHER

Principal Investigators

  • Jie Qiu, doctor · Qilu Hospital of Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
43 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2011-09-30
Completion
2011-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01707615 on ClinicalTrials.gov